Supplementary Figures S2 and S3 from Targeting the Wnt Pathway in Synovial Sarcoma Models
Whitney Barham(Howard Hughes Medical Institute), Josiane E. Eid(Howard Hughes Medical Institute), Michael N. VanSaun(University of Miami), Christina B. Garcia(Howard Hughes Medical Institute), Andrea L. Frump(Howard Hughes Medical Institute), Darren Orton(Vanderbilt University), Barbara Fingleton(Vanderbilt University), Timothy S. Blackwell(University of Michigan), Mario R. Capecchi(University of Utah), Kenyi Saito‐Diaz(University of Georgia), Ethan Lee(Johns Hopkins University), Linda A. Gleaves(Pulmonary and Allergy Associates), Taylor P. Sherrill(Pulmonary and Allergy Associates), Fiona E. Yull(Vanderbilt University)
Cited by 0
Related Papers
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
|Science|2002|2.7k
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
|Journal of Clinical Oncology|2000|1.6k
The structure of the G protein heterotrimer Giα1β1γ2
|Cell|1995|1.1k
Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis
|Cancer Cell|2004|1.1k
The intestinal stem cell markers Bmi1 and Lgr5 identify two functionally distinct populations
|Proceedings of the National Academy of Sciences|2011|824